Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of TASOR2 mRNA | CTD | PMID:23649840 | 17beta-estradiol | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of TASOR2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TASOR2 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAM208B mRNA and Tetrachlorodibenzodioxin results in decreased expression of TASOR2 mRNA | CTD | PMID:32109520 and PMID:33387578 | 4,4'-sulfonyldiphenol | increases methylation | ISO | TASOR2 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of TASOR2 gene | CTD | PMID:31601247 | all-trans-retinoic acid | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of FAM208B mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of TASOR2 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of FAM208B mRNA and aristolochic acid I results in decreased expression of FAM208B protein | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to TASOR2 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TASOR2 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | increases methylation | ISO | TASOR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TASOR2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | TASOR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of TASOR2 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of TASOR2 mRNA | CTD | PMID:31129395 | bisphenol A | affects splicing | ISO | Tasor2 (Mus musculus) | 6480464 | bisphenol A affects the splicing of TASOR2 mRNA | CTD | PMID:37894381 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TASOR2 mRNA | CTD | PMID:30816183 | bortezomib | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of TASOR2 mRNA | CTD | PMID:20977926 | caffeine | affects phosphorylation | ISO | TASOR2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of TASOR2 protein | CTD | PMID:35688186 | cisplatin | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of TASOR2 mRNA | CTD | PMID:27594783 | clobetasol | decreases expression | ISO | Tasor2 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of TASOR2 mRNA | CTD | PMID:27462272 | copper atom | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TASOR2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TASOR2 mRNA | CTD | PMID:20971185 | coumarin | increases phosphorylation | ISO | TASOR2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of TASOR2 protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | Tasor2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of TASOR2 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TASOR2 mRNA | CTD | PMID:20106945 | dorsomorphin | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TASOR2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TASOR2 mRNA | CTD | PMID:29803840 | ethyl methanesulfonate | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of TASOR2 mRNA | CTD | PMID:23649840 | formaldehyde | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of TASOR2 mRNA | CTD | PMID:20655997 and PMID:23649840 | FR900359 | affects phosphorylation | ISO | TASOR2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of TASOR2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FAM208B mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TASOR2 protein | CTD | PMID:32959892 | lead(0) | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Lead results in decreased expression of TASOR2 mRNA | CTD | PMID:19921347 | methyl methanesulfonate | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of TASOR2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of TASOR2 mRNA | CTD | PMID:28001369 | methylmercury chloride | decreases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TASOR2 mRNA | CTD | PMID:28001369 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FAM208B mRNA | CTD | PMID:33387578 | resveratrol | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TASOR2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TASOR2 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of TASOR2 mRNA | CTD | PMID:25895662 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of TASOR2 mRNA | CTD | PMID:25993096 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TASOR2 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Tasor2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of TASOR2 mRNA | CTD | PMID:27339419 and PMID:31919559 | thimerosal | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of TASOR2 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TASOR2 mRNA | CTD | PMID:23411599 and PMID:34492290 | titanium dioxide | decreases expression | ISO | Tasor2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of TASOR2 mRNA | CTD | PMID:29264374 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of TASOR2 mRNA | CTD | PMID:31129395 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of FAM208B mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of TASOR2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | TASOR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TASOR2 mRNA | CTD | PMID:27188386 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TASOR2 mRNA | CTD | PMID:23034163 | vincristine | increases expression | ISO | TASOR2 (Homo sapiens) | 6480464 | Vincristine results in increased expression of TASOR2 mRNA | CTD | PMID:23649840 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
